Table 1. Clinical characteristic of cohort, overall and stratified for cause of CKD, at referral visit.
| Overall (n = 729) | HTN (n = 392) | DN (n = 116) | GN (n = 126) | TIN (n = 69) | PKD (n = 26) | P | |
|---|---|---|---|---|---|---|---|
| Age (years) | 63.6±15.1 | 70.8±8.8 | 65.0 ±10.2 | 48.3±16.4 | 55.1 ±17.1 | 46.0 ±16.0 | <0.001 |
| Male gender (%) | 59.1 | 60.2 | 62.1 | 65.1 | 44.9 | 38.5 | 0.012 |
| Body Mass Index (kg/m 2 ) | 28.9±5.3 | 29.5±5.3 | 29.6±6.1 | 27.9±4.1 | 27.2±5.2 | 27.0±3.9 | <0.001 |
| Smoker (%) | 20.6 | 14.3 | 25.0 | 31.0 | 24.6 | 34.6 | <0.001 |
| Diabetes mellitus (%) | 34.7 | 28.3 | 100 | 15.1 | 10.1 | 0 | <0.001 |
| CV disease (%) | 44.9 | 54.8 | 60.3 | 22.2 | 13.0 | 19.2 | <0.001 |
| LVH (%) | 58.9 | 70.1 | 70.7 | 34.1 | 34.1 | 30.8 | <0.001 |
| CKD stage (%) | <0.001 | ||||||
| Stage I | 5.8 | 1.3 | 3.4 | 19.8 | 7.2 | 11.5 | |
| Stage II | 15.0 | 9.4 | 12.1 | 32.5 | 17.4 | 19.2 | |
| Stage IIIa | 29.1 | 35.2 | 31.0 | 13.5 | 23.2 | 19.2 | |
| Stage IIIb | 32.5 | 37.5 | 31.9 | 19.0 | 31.9 | 26.9 | |
| Stage IV | 17.7 | 16.6 | 21.6 | 15.1 | 20.3 | 23.1 |
Data are mean±SD or % patients. HTN, hypertensive nephropathy; DN, diabetic nephropathy, GN, glomerulonephritis; TIN, tubulointerstitial nephropathy; PKD, autosomal polycystic kidney disease; CV, cardiovascular; LVH, left ventricular hyperthrophy